Spyre Therapeutics (SYRE) Earnings Date & Reports

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

SYRE is expected to report earnings to rise 2.59% to -75 cents per share on August 06

Spyre Therapeutics SYRE Stock Earnings Reports

Q2'26

Est.

$-0.76

Q1'26

Missed

by $0.07

Q4'25

Est.

$-0.70

Q3'25

Beat

by $0.62

Q2'25

Beat

by $0.26

The last earnings report on May 05 showed earnings per share of -74 cents, missing the estimate of -67 cents. With 545.52K shares outstanding, the current market capitalization sits at 8.14B.

View a ticker or compare two or three

Compare

SYRE

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for SYRE